BACKGROUND:People with chronic heart failure (HF) suffer from numerous symptoms that worsen quality of life. The CASA (Collaborative Care to Alleviate Symptoms and Adjust to Illness) intervention was designed to improve symptoms and quality of life by integrating palliative and psychosocial care into chronic care. OBJECTIVE: Our aim was to determine the feasibility and acceptability of CASA and identify necessary improvements. METHODS: We conducted a prospective mixed-methods pilot trial. The CASA intervention included (1) nurse phone visits involving structured symptom assessments and guidelines to alleviate breathlessness, fatigue, pain, or depression; (2) structured phone counseling targeting adjustment to illness and depression if present; and (3) weekly team meetings with a palliative care specialist, cardiologist, and primary care physician focused on medical recommendations to primary care providers (PCPs, physician or nurse practioners) to improve symptoms. Study subjects were outpatients with chronic HF from a Veteran's Affairs hospital (n=15) and a university hospital (n=2). Measurements included feasibility (cohort retention rate, medical recommendation implementation rate, missing data, quality of care) and acceptability (an end-of-study semi-structured participant interview). RESULTS:Participants were male with a median age of 63 years. One withdrew early and there were <5% missing data. Overall, 85% of 87 collaborative care team medical recommendations were implemented. All participants who screened positive for depression were either treated for depression or thought to not have a depressive disorder. In the qualitative interviews, patients reported a positive experience and provided several constructive critiques. CONCLUSIONS: The CASA intervention was feasible based on participant enrollment, cohort retention, implementation of medical recommendations, minimal missing data, and acceptability. Several intervention changes were made based on participant feedback.
RCT Entities:
BACKGROUND:People with chronic heart failure (HF) suffer from numerous symptoms that worsen quality of life. The CASA (Collaborative Care to Alleviate Symptoms and Adjust to Illness) intervention was designed to improve symptoms and quality of life by integrating palliative and psychosocial care into chronic care. OBJECTIVE: Our aim was to determine the feasibility and acceptability of CASA and identify necessary improvements. METHODS: We conducted a prospective mixed-methods pilot trial. The CASA intervention included (1) nurse phone visits involving structured symptom assessments and guidelines to alleviate breathlessness, fatigue, pain, or depression; (2) structured phone counseling targeting adjustment to illness and depression if present; and (3) weekly team meetings with a palliative care specialist, cardiologist, and primary care physician focused on medical recommendations to primary care providers (PCPs, physician or nurse practioners) to improve symptoms. Study subjects were outpatients with chronic HF from a Veteran's Affairs hospital (n=15) and a university hospital (n=2). Measurements included feasibility (cohort retention rate, medical recommendation implementation rate, missing data, quality of care) and acceptability (an end-of-study semi-structured participant interview). RESULTS:Participants were male with a median age of 63 years. One withdrew early and there were <5% missing data. Overall, 85% of 87 collaborative care team medical recommendations were implemented. All participants who screened positive for depression were either treated for depression or thought to not have a depressive disorder. In the qualitative interviews, patients reported a positive experience and provided several constructive critiques. CONCLUSIONS: The CASA intervention was feasible based on participant enrollment, cohort retention, implementation of medical recommendations, minimal missing data, and acceptability. Several intervention changes were made based on participant feedback.
Authors: Jürgen Unützer; Wayne Katon; Christopher M Callahan; John W Williams; Enid Hunkeler; Linda Harpole; Marc Hoffing; Richard D Della Penna; Polly Hitchcock Noël; Elizabeth H B Lin; Patricia A Areán; Mark T Hegel; Lingqi Tang; Thomas R Belin; Sabine Oishi; Christopher Langston Journal: JAMA Date: 2002-12-11 Impact factor: 56.272
Authors: Brad Smith; Emma Forkner; Barbara Zaslow; Richard A Krasuski; Karl Stajduhar; Michael Kwan; Robert Ellis; Autumn Dawn Galbreath; Gregory L Freeman Journal: Am J Manag Care Date: 2005-11 Impact factor: 2.229
Authors: Janine Archer; Peter Bower; Simon Gilbody; Karina Lovell; David Richards; Linda Gask; Chris Dickens; Peter Coventry Journal: Cochrane Database Syst Rev Date: 2012-10-17
Authors: Sarah J Goodlin; Paul J Hauptman; Robert Arnold; Kathleen Grady; Ray E Hershberger; Jean Kutner; Frederick Masoudi; John Spertus; Kathleen Dracup; James F Cleary; Ruth Medak; Kathy Crispell; Ileana Piña; Brad Stuart; Christy Whitney; Thomas Rector; Joan Teno; Dale G Renlund Journal: J Card Fail Date: 2004-06 Impact factor: 5.712
Authors: Veerawat Phongtankuel; Lauren Meador; Ronald D Adelman; Jordan Roberts; Charles R Henderson; Sonal S Mehta; Tessa Del Carmen; M C Reid Journal: Am J Hosp Palliat Care Date: 2016-11-10 Impact factor: 2.500
Authors: Mary Pilar Ingle; Devon Check; Daniel Hogan Slack; Sarah H Cross; Natalie C Ernecoff; Daniel D Matlock; Dio Kavalieratos Journal: J Pain Symptom Manage Date: 2021-10-29 Impact factor: 3.612
Authors: David B Bekelman; Larry A Allen; Connor F McBryde; Brack Hattler; Diane L Fairclough; Edward P Havranek; Carolyn Turvey; Paula M Meek Journal: JAMA Intern Med Date: 2018-04-01 Impact factor: 21.873
Authors: David B Bekelman; Larry A Allen; Jamie Peterson; Brack Hattler; Edward P Havranek; Diane L Fairclough; Connor F McBryde; Paula M Meek Journal: Contemp Clin Trials Date: 2016-09-12 Impact factor: 2.261
Authors: Rachel Wells; James Nicholas Dionne-Odom; Andres Azuero; Harleah Buck; Deborah Ejem; Kathryn L Burgio; Macy L Stockdill; Rodney Tucker; Salpy V Pamboukian; Jose Tallaj; Sally Engler; Konda Keebler; Sheri Tims; Raegan Durant; Keith M Swetz; Marie Bakitas Journal: J Pain Symptom Manage Date: 2021-02-05 Impact factor: 5.576